genesistherapeutics.aiHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $308.66MM
Genesis Therapeutics excels in AI-powered drug discovery, targeting novel proteins and untapped chemical spaces. Their advanced molecular AI platform speeds up the creation of new medicines. The team, skilled in drug hunting, deep learning, and software engineering, pushes AI in biochemistry. Their pioneering method combines 3D spatial graph modeling with cutting-edge molecular simulation to generate novel drug candidates. Genesis Therapeutics is redefining biotech, focusing on severe disorders with innovative AI integration.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Genesis Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.